Company profile: J+D Forecasting
1.1 - Company Overview
Company description
- Provider of pharmaceutical forecasting software, pharma training, and consultancy services as a business consulting firm.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to J+D Forecasting
Eurogentec
HQ: Belgium
Website
- Description: Provider of GMP biopharmaceutical manufacturing and life science solutions for research, diagnostic and pharmaceutical markets, including large-scale production of plasmid DNA, recombinant proteins, antibody fragments, mRNA, vaccines and conjugates; complex and NGS oligonucleotides; peptide-oligo conjugates; custom RNA/DNA aptamers; reagents and kits, in compliance with local and international standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurogentec company profile →
Rokshaw Laboratories
HQ: United Kingdom
Website
- Description: Provider of family-owned Specials manufacturing, delivering trusted service.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rokshaw Laboratories company profile →
Altasciences
HQ: Canada
Website
- Description: Provider of early phase contract research services for pharmaceutical and biotechnology companies, including preclinical safety testing; Phase I–II clinical pharmacology; bioanalysis from preclinical to Phase IV (LC-MS/MS and ligand binding assays); formulation, manufacturing, and analytical services; specialized renal and hepatic impairment studies via external partners; and cardiac safety assessment including QT prolongation evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altasciences company profile →
Cytovance Biologics
HQ: United States
Website
- Description: Provider of cGMP production of therapeutic proteins and antibodies from mammalian cell culture (CHO), microbial fermentation (E. coli), and transgenic processes. Full-service CDMO offering cell line development, process development, purification development, and stability testing; FDA inspected.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytovance Biologics company profile →
Ten23 Health
HQ: Switzerland
Website
- Description: Provider of biologics drug product contract development and manufacturing services focused on injectable treatments. Offers sterile product manufacturing using isolator technology; clinical fill-finish and commercial supplies for vials, syringes, and cartridges; manufacturing process transfer, characterization, and validation; stability samples, reference standards, and pre-clinical supplies; and analytical testing and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ten23 Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for J+D Forecasting
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to J+D Forecasting
2.2 - Growth funds investing in similar companies to J+D Forecasting
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for J+D Forecasting
4.2 - Public trading comparable groups for J+D Forecasting
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →